Focused Alpha’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$853K Sell
5,873
-136
-2% -$18.8K 0.21% 93
2026
Q2
$772K Sell
6,009
-160
-3% -$18.7K 0.2% 102
2026
Q1
$742K Buy
6,169
+1,598
+35% +$184K 0.23% 93
2025
Q4
$481K Buy
+4,571
New +$429K 0.14% 150

Other funds holding MRK

Focused Alpha's MRK Position: Q3 2026 in Review

Focused Alpha reduced its Merck (MRK) stake by 2.3% in Q3 2026, selling an estimated $18.8K and leaving 5,873 shares worth $853K. The position accounts for 0.21% of the portfolio, ranked #93.

Focused Alpha first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Focused Alpha held 5,873 shares of Merck worth $853K as of Q3 2026.
  • Focused Alpha sold 136 Merck shares in Q3 2026, an estimated $18.8K.
  • Merck made up 0.21% of Focused Alpha's portfolio in Q3 2026, its #93 holding.
  • Focused Alpha first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.